Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 21.54
(0.0%)
USD 21.54
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 10.49 Billion JPY | 10142.29% |
| 2023 | 102.45 Million JPY | -42.58% |
| 2022 | 178.43 Million JPY | 132.3% |
| 2021 | 76.81 Million JPY | 7.07% |
| 2020 | 71.74 Million JPY | 50.85% |
| 2019 | 47.55 Million JPY | -15.08% |
| 2018 | 56 Million JPY | -21.14% |
| 2017 | 71.01 Million JPY | -2.7% |
| 2016 | 72.98 Million JPY | -99.23% |
| 2015 | 9.42 Billion JPY | -4.64% |
| 2014 | 9.88 Billion JPY | 37.46% |
| 2013 | 7.18 Billion JPY | -14.8% |
| 2012 | 8.43 Billion JPY | 42.65% |
| 2011 | 5.91 Billion JPY | -27.41% |
| 2010 | 8.14 Billion JPY | -8.77% |
| 2009 | 8.93 Billion JPY | -15.75% |
| 2008 | 10.6 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 66.87 Million JPY | -13.08% |
| 2024 FY | 10.49 Billion JPY | 10142.29% |
| 2024 Q1 | 76.94 Million JPY | -24.9% |
| 2024 Q4 | 10.49 Billion JPY | 15273.12% |
| 2024 Q3 | 68.26 Million JPY | 2.07% |
| 2023 Q4 | 102.45 Million JPY | -14.42% |
| 2023 Q1 | 153.19 Million JPY | -14.15% |
| 2023 Q2 | 120.07 Million JPY | -21.62% |
| 2023 Q3 | 119.71 Million JPY | -0.29% |
| 2023 FY | 102.45 Million JPY | -42.58% |
| 2022 Q3 | 177.5 Million JPY | 33.36% |
| 2022 Q2 | 133.1 Million JPY | 47.03% |
| 2022 Q1 | 90.53 Million JPY | 17.84% |
| 2022 FY | 178.43 Million JPY | 132.3% |
| 2022 Q4 | 178.43 Million JPY | 0.52% |
| 2021 Q1 | 7.68 Billion JPY | 5.37% |
| 2021 Q4 | 76.82 Million JPY | -99.11% |
| 2021 FY | 76.81 Million JPY | 7.07% |
| 2021 Q3 | 8.67 Billion JPY | -6.18% |
| 2021 Q2 | 9.24 Billion JPY | 20.28% |
| 2020 Q2 | 3.14 Billion JPY | -28.75% |
| 2020 FY | 71.74 Million JPY | 50.85% |
| 2020 Q4 | 7.29 Billion JPY | 119.6% |
| 2020 Q1 | 4.4 Billion JPY | -14.74% |
| 2020 Q3 | 3.32 Billion JPY | 5.8% |
| 2019 Q2 | 6.37 Billion JPY | 1.48% |
| 2019 FY | 47.55 Million JPY | -15.08% |
| 2019 Q1 | 6.28 Billion JPY | 7.3% |
| 2019 Q3 | 5.86 Billion JPY | -8.03% |
| 2019 Q4 | 5.16 Billion JPY | -11.81% |
| 2018 Q1 | 5.74 Billion JPY | 12.29% |
| 2018 FY | 56 Million JPY | -21.14% |
| 2018 Q2 | 6.06 Billion JPY | 5.5% |
| 2018 Q3 | 6.06 Billion JPY | 0.05% |
| 2018 Q4 | 5.85 Billion JPY | -3.51% |
| 2017 Q3 | 5.31 Billion JPY | 8.23% |
| 2017 FY | 71.01 Million JPY | -2.7% |
| 2017 Q4 | 5.11 Billion JPY | -3.63% |
| 2017 Q2 | 4.9 Billion JPY | -7.82% |
| 2017 Q1 | 5.32 Billion JPY | -2.26% |
| 2016 Q2 | 7.42 Billion JPY | 0.54% |
| 2016 Q3 | 6.17 Billion JPY | -16.79% |
| 2016 Q4 | 5.44 Billion JPY | -11.82% |
| 2016 FY | 72.98 Million JPY | -99.23% |
| 2016 Q1 | 7.38 Billion JPY | -21.66% |
| 2015 FY | 9.42 Billion JPY | -4.64% |
| 2015 Q4 | 9.42 Billion JPY | -11.05% |
| 2015 Q3 | 10.59 Billion JPY | 0.24% |
| 2015 Q2 | 10.56 Billion JPY | 21.62% |
| 2015 Q1 | 8.69 Billion JPY | -12.06% |
| 2014 Q3 | 11.99 Billion JPY | 59.3% |
| 2014 Q1 | 7.33 Billion JPY | 1.96% |
| 2014 Q4 | 9.88 Billion JPY | -17.62% |
| 2014 Q2 | 7.53 Billion JPY | 2.73% |
| 2014 FY | 9.88 Billion JPY | 37.46% |
| 2013 Q2 | 6.75 Billion JPY | -15.64% |
| 2013 FY | 7.18 Billion JPY | -14.8% |
| 2013 Q3 | 7.08 Billion JPY | 4.79% |
| 2013 Q1 | 8.01 Billion JPY | -5.05% |
| 2013 Q4 | 7.18 Billion JPY | 1.5% |
| 2012 FY | 8.43 Billion JPY | 42.65% |
| 2012 Q1 | 7.94 Billion JPY | 34.35% |
| 2012 Q2 | 8.61 Billion JPY | 8.34% |
| 2012 Q3 | 8.19 Billion JPY | -4.84% |
| 2012 Q4 | 8.43 Billion JPY | 2.99% |
| 2011 Q2 | 8.55 Billion JPY | 13.75% |
| 2011 FY | 5.91 Billion JPY | -27.41% |
| 2011 Q1 | 7.52 Billion JPY | -7.71% |
| 2011 Q3 | 6.15 Billion JPY | -28.06% |
| 2011 Q4 | 5.91 Billion JPY | -3.88% |
| 2010 Q2 | 8.47 Billion JPY | 0.0% |
| 2010 FY | 8.14 Billion JPY | -8.77% |
| 2010 Q4 | 8.14 Billion JPY | 2.45% |
| 2010 Q3 | 7.95 Billion JPY | -6.14% |
| 2009 Q4 | 8.93 Billion JPY | -31.63% |
| 2009 Q3 | 13.06 Billion JPY | 0.0% |
| 2009 FY | 8.93 Billion JPY | -15.75% |
| 2008 FY | 10.6 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 368.12 Thousand USD | -2850569.883% |
| Bruush Oral Care Inc. | - USD | -Infinity% |
| CCA Industries, Inc. | 61.03 Thousand USD | -17194722.219% |
| DSwiss, Inc. | 37 Thousand USD | -28358996.314% |
| EOS, Inc. | 122.56 Thousand USD | -8561747.806% |
| Greyson International, Inc. | 59.66 Thousand USD | -17589574.824% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | - USD | -Infinity% |
| Infusion Brands International, Inc. | 2.34 Million USD | -446940.751% |
| Mandom Corporation | 3.23 Million USD | -324046.005% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | 17.29 Thousand USD | -60679904.626% |
| Oliveda International, Inc. | - USD | -Infinity% |
| PacificHealth Laboratories, Inc. | 57.17 Thousand USD | -18352791.796% |
| Prosperous Future Holdings Limited | 2.67 Million USD | -392190.56% |
| PURE Bioscience, Inc. | 2.94 Million USD | -355749.44% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 6.15 Million USD | -170448.04% |
| Sentient Brands Holdings Inc. | 1.39 Million USD | -753650.436% |
| Sunset Capital Assets, Inc. | 64.55 Thousand USD | -16255050.407% |
| The Stephan Co. | 1.26 Million USD | -828155.722% |
| Turner Valley Oil & Gas, Inc. | 166.66 Thousand USD | -6296438.524% |
| Winning Brands Corporation | 2.88 Million USD | -363040.197% |
| Warpaint London PLC | 6.93 Million USD | -151185.014% |
| Zoono Group Limited | 482.91 Thousand USD | -2172957.729% |
| Zurvita Holdings, Inc. | 858.12 Thousand USD | -1222795.912% |